Home » MiRXES Earns CE Mark for COVID-19/Flu Test
MiRXES Earns CE Mark for COVID-19/Flu Test
Singapore-based MiRXES’ Fortitude SARS-CoV-2/influenza test kit has received a CE mark in Europe and regulatory clearance in Singapore.
The multiplex test combines a reverse transcription polymerase chain reaction (RT-PCR) COVID-19 test kit with assays for influenza A and B, and can distinguish between SARS-CoV-2 viruses and flu pathogens.
The company said it is currently seeking Emergency Use Authorization from the FDA and approval from Japan’s Pharmaceuticals and Medical Devices Agency for the test.
Upcoming Events
-
21Mar
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr